课题基金 / 基金详情

EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION

EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
白细胞介素 5 受体激活对嗜酸性粒细胞信号转导的影响
批准号:
6273183
负责人:
PAUL JOHN BERTICS
金额:
$22.41万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

PAUL JOHN BERTICS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Allergic inflammation and asthma are characterized by eosinophilia and the increased production of interleukin 5 (Il-5) in blood and affected tissues. Eosinophils can promote both bronchial smooth muscle contraction and increased permeability of bronchial mucosa. Eosinophil- derived mediators [e.g., granule proteins, reactive oxygen species and leukotriene C4 (LTC4)], can evoke hyper-responsiveness, epithelial damage, inflammation and bronchoconstriction. IL-5 is known to regulate eosinophil function, which can contribute to the pathogenesis of asthma. For example, IL-5 stimulation of blood eosinophils can produce several functional changes that mirror the phenotypic characteristics of the airway eosinophil, and these IL-5-induced changes include the priming LTC4 release, the increased membrane expression of CD11b/CD18, the enhance adherence to endothelial cells, and prolonged survival. Because little is known about IL-5 signal transduction in eosinophils, the present project is designed to explore the mechanisms by which Il-5 mediates alterations in eosinophil function, thereby increasing its inflammatory potential. This proposal will test a model of IL-5 intracellular signaling processes that is based on studies by us and others on the IL-5 family of cytokines. Our overall goal is to assess the importance of various aspects of this model to the intracellular events in human eosinophils stimulated with IL-5, and to relate these signaling processes to eosinophil function. The studies will focus on functional changes, namely chemotaxis, adherence to endothelium, LTC4 generation and suppression of apoptotic cell death, that are of particular relevance to the inflammatory capacity and accumulation of eosinophils in the pathogenesis of asthma. The proposed research centers around our observation that IL-5 stimulates the tyrosine phosphorylation of several cellular proteins, including the phosphorylation and activation of a 45-kDa mitogen- activated protein kinase (MAP kinase). The central hypothesis is developed that multiple pathways are involved in the IL-5 mediated tyrosine phosphorylation and activation of MAP kinases in eosinophils. To test this hypothesis, we will analyze the events that link IL-5 receptor activation to MAP kinase stimulation, such as pathways encompassing tyrosine kinases, Ras, protein kinase C, and/or pertussis toxin-sensitive G-proteins. Secondly, we will also examine selected processes that may result from IL-5-stimulated MAP kinase activity, including the regulation of phospholipase A2, ribosomal S6 kinase II (Rsk) and the hematopoietic transcription factor GATA-2, since these proteins are established MAP kinase substrates. These investigations lead to the related hypothesis that MAP kinase activation is a key intracellular mechanism, that along with other signaling events, is associated with IL-5 mediated changes in eosinophil function, including the priming of LTC4 generation, increased adherence to endothelial cells, chemotaxis and suppression of apoptotic cell death. In sum, it is anticipated that these studies will lead to a greater understanding of the molecular processes associated with eosinophilic inflammation that is a major characteristic of the pathophysiology of asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signal Transduction Pathways in Eosinophil Priming
  • 批准号:
    7843280
  • 项目类别:
  • 资助金额:
    $38.8万
  • 财政年份:
    2009
  • 负责人:
    PAUL JOHN BERTICS
  • 依托单位:
Signal Transduction Pathways in Eosinophil Priming
  • 批准号:
    7391415
  • 项目类别:
  • 资助金额:
    $38.78万
  • 财政年份:
    2007
  • 负责人:
    PAUL JOHN BERTICS
  • 依托单位:
Molecular Analysis Using Liquid Crystal Technology
  • 批准号:
    7603015
  • 项目类别:
  • 资助金额:
    $25.2万
  • 财政年份:
    2007
  • 负责人:
    PAUL JOHN BERTICS
  • 依托单位:
Molecular Analysis Using Liquid Crystal Technology
  • 批准号:
    7240191
  • 项目类别:
  • 资助金额:
    $25.2万
  • 财政年份:
    2007
  • 负责人:
    PAUL JOHN BERTICS
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: